Please add 11cabfa9709432e9918fd20a96d9deb8@lists.pharmasentry.com to your e-mail address book to ensure you receive our eNews
August 5, 2010
Free Online Continuing Education: Click here for CME. Click here for CEUs.

This week's featured Continuing Education Program
Management of an HIV Patient Population


Register Today for the Fall Forum at the Bellagio in Las Vegas!
Contact Jeremy Williams at jwilliams@namcp.org for information regarding conference discounts. CLICK HERE to visit our conference website! The agenda has been posted! Be sure to check out the agenda page at the website!

November 4-5, 2010
Bellagio Hotel and Casino, Las Vegas, NV


News Update
Click Title for complete article or click Summary for overview of each article.

FDA Approves Vaccines for the 2010-2011 Influenza Season
From Targeted News Service - Jul 31, 2010
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release: Seasonal influenza vaccine protects against three strains of influenza, including the 2009 H1N1 influenza virus, which caused the 2009 pandemic.
[ Summary ]

MCG study emphasizes the impact of vitamin D [The Augusta Chronicle, Ga.]
From Augusta Chronicle (GA) - Jul 30, 2010
July 30--Asian Brown could feel the difference when he started taking vitamin D supplements, and the 16-year-old student of A.R. Johnson Health Science and Engineering Magnet School might be just the beginning.
[ Summary ]

MCOs Offering Both Medicare Advantage and Part D Plans are More Than Twice as Likely to Cover Avastin and Herceptin as a Drug Benefit on Their Medicare Advantage Plans
From PharmaLive News Archive - Jul 28, 2010
NASHVILLE, Tenn. and Glen Rock, N.J., July 29 /PRNewswire/ -- HealthLeaders-InterStudy and Fingertip Formulary find that surveyed pharmacy directors whose managed care organizations offer both a Medicare Advantage (MA) and a Part D plan were more than twice as likely to cover Roche/Genentech/Chugai's Avastin and Herceptin for the treatment of multiple cancer indications as a drug benefit on their MA plans as on their stand-alone Part D plans.
[ Summary ]





Genomics and Biotechnology
Click Title for complete article or click Summary for overview of each article.

FDA: Stem Cell Trial Can Proceed
From PharmaLive News Archive - Aug 01, 2010
MENLO PARK, Calif., July 31, 2010 (UPI) - The Food and Drug Administration has given approval to proceed with the world?s first human clinical trial of a human embryonic stem cell-based therapy.
[ Summary ]

Adult stem cell studies abound for heart, diabetes, MS; far ahead of embryonic research
From Canadian Press DataFile - Aug 02, 2010
NEW YORK _ A few months ago, Dr. Thomas Einhorn was treating a patient with a broken ankle that would not heal, even with multiple surgeries. Einhorn drew bone marrow from the man's pelvic bone with a needle, condensed it to about four teaspoons of rich red liquid, and injected that into his ankle. Four months later the ankle was healed. Einhorn's experience is not a rigorous study.
[ Summary ]

Geron to Proceed with First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
From PharmaLive News Archive - Jul 29, 2010
MENLO PARK, Calif.--(BUSINESS WIRE)--Jul 30, 2010 - Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
[ Summary ]





FDA: New Treatments and Technology
Click Title for complete article or click Summary for overview of each article.

FDA Approves New Taxotere (docetaxel) Injection Concentrate Formulation
From PharmaLive News Archive - Aug 04, 2010
BRIDGEWATER, N.J., Aug. 5 /PRNewswire/ -- Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere (docetaxel) Injection Concentrate.
[ Summary ]

FDA Advisory Committee Recommended US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
From PharmaLive News Archive - Jul 27, 2010
WILMINGTON, DE ? July 28, 2010 ? AstraZeneca today announced that the US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended the FDA approve AstraZeneca?s investigational drug ticagrelor for the reduction of thrombotic events in patients with Acute Coronary Syndromes (ACS).
[ Summary ]

FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis
From PharmaLive News Archive - Jul 27, 2010
Darmstadt, Germany, July 28, 2010 - Merck KGaA announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS).
[ Summary ]





Oncology
Click Title for complete article or click Summary for overview of each article.

Patients, hospitals wrestle over tumor tissue [The Philadelphia Inquirer]
From Philadelphia Inquirer (PA) - Jul 29, 2010
July 29--All Niki Perry wanted was pieces of her own brain, and she got angrier by the day as she tried to get them. She needed samples of her brain tumor this spring to enter clinical trials she hoped might save her life. What she got, she said, was delay and disappointment.
[ Summary ]

New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study
From PR Newswire US - Jul 28, 2010
SEATTLE, July 28 Dendreon Corporation announced today the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine, showing that PROVENGE® demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostate cancer.
[ Summary ]





Education

CLICK THE FOLLOWING TITLES TO PARTICIPATE IN THE ONLINE CME/CEU

Inattention, Hyperactivity and Impulsivity: The Diagnosis, Management and Treatment of Behavioral Deficits Attributed to ADHD
- Supported by an educational grant from Ortho-McNeil Janssen Scientific Affairs, LLC and Shire Pharmaceuticals

Evolution of Personalized Medicine: The Role of Pharmacogenomics in Managed Care
- Supported by an educational grant from Genzyme Corporation


Effective Diagnosis and Treatment of Early Parkinson?s Disease
- Supported by an educational grant from UCB Pharmaceuticals


Journal of Managed Care Medicine
Your Logo Here

Journal of Managed Care Medicine Vol 13, Issue 2 Table of Contents

Below you will find the table of contents for the current issue of JMCM. You can click here to visit our main journal page, or click on each individual article below to visit their article page and then download the PDF!




Click the titles below to visit the indvidual article download page.

Keys to Detection of VTE
Darrell W. Harrington, MD, FACP

Understanding, Diagnosing, and Managing Fibromyalgia
Stuart Silverman, MD, FACP FACR

Bipolar Disorder: Developing a Cost Effective Management Program
Jay Faber, MD

Multiple Myeloma: What Managed Care Needs to Know
Laura Raftery, MD

Targeted Therapies in Non Small Cell Lung Cancer
Ramaswamy Govindan, MD

Optimizing Patient Management: Improving Managed Care Performance and Provider/Plan Communication
Wendy J. Evans, PhD, James D. Keller1, MD, and Mark I. Evans, MD

Complete 13.2 Issue

Join NAMCP's LinkedIn Group!

This is a GREAT way to network with other members, send them direct messages, post comments or questions and learn more about your colleagues working in other areas of managed care! If you are a member of this professional, social network, please search groups for NAMCP and request to join our group for ongoing discussions, networking and interaction with other members!

Job Postings

Visit NAMCP's Career Center!

To find a job or fill a position, visit http://careers.namcp.org. You can also click on the links following each individual job below to be taken to their new page on our career center.

Job seekers and employers have discovered the advantages of searching online for the best jobs and for qualified candidates to fill them. But, the mass-market approach of the mega job boards may not be your best avenue.

NAMCP's Career Center gives employers and job seeking managed care professionals a better way to find one another and make that perfect career fit.

For Job Seekers: Post your resume; Search job listings; Set up Search Agents; and have new postings sent to you via email.

For Employers: Post your jobs; Target a focused audience of candidates; Search resumes; Track applications; Promote your company online.


If you have an available position or have an interest in our placement service, please contact David Mara at (804)527-1905 or e-mail at dmara@namcp.org.

Genomics Biotech Institute eNews for August 5, 2010
Produced by NAMCP & Genomics Biotech Institute
4435 Waterfront Drive, Suite 101
Glen Allen, VA 23060
Telephone: 804-527-1905
Fax: 804-747-5316

Click "Opt-out of this newsletter" at the top of the newsletter or contact Jeremy Williams at jwilliams@namcp.org or 804-527-1905 to be taken off the list

 
NAMCP Medical Directors Resource Centers

The purpose of NAMCP's Medical Directors Resource Centers is to provide Medical Directors with access to disease specific information and resources and to improve patient outcomes.

Accessing NAMCP's Medical Directors Resource Centers will allow you to:

  • Use screening tools to diagnose
  • Access treatment and best practice guidelines
  • Improve patient adherence and compliance
  • Improve patient outcomes
  • Better manage patients
  • Review cost of treatment versus overall economic burden
  • Provide resources for your network physicians
  • Provide resources for patients

    CLICK HERE to access the Obesity Resource Center

    CLICK HERE to access the Sleep Resource Center

    CLICK HERE to access the Diabetes Resource Center


  • CME on the Web
    Click each to view

    See below or visit www.namcp.org/cmeonline.htm

    Parkinson's Disease: A How To Series

    Bipolar Disorder: Developing a Cost Effective Disease Management Program

    Multiple Myeloma: What Managed Care Needs To Know

    Management of an HIV Patient Population

    The Relationship and Impact of Diabetes and Cardiovascular Disease

    Clinical and Financial Implications of Wound Care Management Across the Care Continuum

    History, Injury and Blood Flow: The Keys to Detection of Venous Thromboembolism

    Prevention, Diagnosis & Treatment of COPD

    Current Concepts in Managing Dyslipidemia


    NAMCP Behavioral Health Resource Center

    Preventative Behavioral Health Treatment: Stress and Medical Illness

    New studies are proving how inextricably linked stress is to physical health. Stress may be affecting your patient's health in more ways than you think. Discover the latest links between stress and serious illness. For more info please click here.

    If you are interested in the NAMCP Behavioral Health Resource Center, please contact Katie Eads at 804-527-1905 or keads@namcp.org.


    GENOMICS BIOTECH INSTITUTE
    Click each to view

    Join GBI

    Become a Corporate Member 

    Learn more at www.genomics-biotech.org 


    NAMCP INFORMATION
    Click each to view

    Join NAMCP

    Medical Directors Insitute

    Health Management Institute

    Become a Corporate Member 

    Learn more at www.namcp.org 


    For More Information Contact:

    Publisher:
    Jeremy Williams, jwilliams@namcp.org or 804-527-1905

    Advertising Sales:
    Peter Palmer, peter@promedgroup.net or 856-795-5777 ext. 13

    Vice President, Sales and Marketing:
    Sloane Reed, sreed@namcp.org or 804-527-1905


     
    namcp namcp
    Powered By: pharmasentry